Sarah Shizuko Morimoto1, Faith M Gunning2, Bruce E Wexler3, Willie Hu2, Irena Ilieva2, Jiacheng Liu4, Juliana Nitis2, George S Alexopoulos2. 1. Institute of Geriatric Psychiatry, Weill Cornell Medical College, White Plains, NY. Electronic address: ssm9006@med.cornell.edu. 2. Institute of Geriatric Psychiatry, Weill Cornell Medical College, White Plains, NY. 3. Department of Psychiatry, Yale University Medical School, New Haven, CT. 4. Zhongda Hospital, Medical School of Southeast University, Nanjing, China.
Abstract
OBJECTIVES: Executive dysfunction (ED) is a predictor of poor treatment response of late-life depression to pharmacotherapy. In response to the consistency of these findings, we designed neuroplasticity-based computerized cognitive remediation (nCCR-GD) intervention to target and improve ED in patients who failed to remit with antidepressant treatment. This study tests the hypothesis that ED at baseline will predict favorable treatment response to nCCR-GD. METHODS: 11 elderly patients with treatment-resistant major depression were treated with a 30-hour, 4-week, unblinded, nCCR-GD treatment trial. Neuropsychological performance was assessed at baseline and after treatment ceased. RESULTS: ED at baseline was associated with greater reduction in Montgomery-Asberg Depression Rating Scale score over the 4-week treatment β = -0.74, F(2,8) = 10.85, p = 0.009, R(2) = 0.55. CONCLUSIONS: ED predicts favorable treatment response to nCCR-GD in older adults suffering from major depression resistant to antidepressants. This finding is opposed to studies testing pharmacotherapy where ED predicts poorer treatment response.
OBJECTIVES: Executive dysfunction (ED) is a predictor of poor treatment response of late-life depression to pharmacotherapy. In response to the consistency of these findings, we designed neuroplasticity-based computerized cognitive remediation (nCCR-GD) intervention to target and improve ED in patients who failed to remit with antidepressant treatment. This study tests the hypothesis that ED at baseline will predict favorable treatment response to nCCR-GD. METHODS: 11 elderly patients with treatment-resistant major depression were treated with a 30-hour, 4-week, unblinded, nCCR-GD treatment trial. Neuropsychological performance was assessed at baseline and after treatment ceased. RESULTS: ED at baseline was associated with greater reduction in Montgomery-Asberg Depression Rating Scale score over the 4-week treatment β = -0.74, F(2,8) = 10.85, p = 0.009, R(2) = 0.55. CONCLUSIONS: ED predicts favorable treatment response to nCCR-GD in older adults suffering from major depression resistant to antidepressants. This finding is opposed to studies testing pharmacotherapy where ED predicts poorer treatment response.
Authors: Sarah Shizuko Morimoto; Faith M Gunning; Dora Kanellopoulos; Christopher F Murphy; Sibel A Klimstra; Robert E Kelly; George S Alexopoulos Journal: Int J Geriatr Psychiatry Date: 2011-05-25 Impact factor: 3.485
Authors: N Raz; F M Gunning; D Head; J H Dupuis; J McQuain; S D Briggs; W J Loken; A E Thornton; J D Acker Journal: Cereb Cortex Date: 1997 Apr-May Impact factor: 5.357
Authors: Patricia A Areán; Patrick Raue; R Scott Mackin; Dora Kanellopoulos; Charles McCulloch; George S Alexopoulos Journal: Am J Psychiatry Date: 2010-06-01 Impact factor: 18.112
Authors: Faith M Gunning-Dixon; Matthew J Hoptman; Kelvin O Lim; Christopher F Murphy; Sibel Klimstra; Vassilios Latoussakis; Magdalena Majcher-Tascio; Jan Hrabe; Babak A Ardekani; George S Alexopoulos Journal: Am J Geriatr Psychiatry Date: 2008-04 Impact factor: 4.105
Authors: R Scott Mackin; J Craig Nelson; Kevin Delucchi; Patrick Raue; Amy Byers; Deborah Barnes; Derek D Satre; Kristine Yaffe; George S Alexopoulos; Patricia A Arean Journal: Am J Geriatr Psychiatry Date: 2013-11-16 Impact factor: 4.105
Authors: Howard J Aizenstein; Meryl A Butters; Minjie Wu; Laura M Mazurkewicz; V Andrew Stenger; Peter J Gianaros; James T Becker; Charles F Reynolds; Cameron S Carter Journal: Am J Geriatr Psychiatry Date: 2009-01 Impact factor: 4.105
Authors: Sarah Shizuko Morimoto; Bruce E Wexler; Jiacheng Liu; Willie Hu; Joanna Seirup; George S Alexopoulos Journal: Nat Commun Date: 2014-08-05 Impact factor: 14.919
Authors: Katie L Bessette; Aimee J Karstens; Natania A Crane; Amy T Peters; Jonathan P Stange; Kathleen H Elverman; Sarah Shizuko Morimoto; Sara L Weisenbach; Scott A Langenecker Journal: Neuropsychol Rev Date: 2020-01-15 Impact factor: 7.444
Authors: Dora Kanellopoulos; Victoria Wilkins; Jimmy Avari; Lauren Oberlin; Lindsay Arader; Merete Chaplin; Samprit Banerjee; George S Alexopoulos Journal: Am J Geriatr Psychiatry Date: 2020-01-25 Impact factor: 4.105
Authors: Sara N Rushia; Al Amira Safa Shehab; Jeffrey N Motter; Dakota A Egglefield; Sophie Schiff; Joel R Sneed; Ernst Garcon Journal: World J Radiol Date: 2020-05-28